TABLE 3.
Period 1 | Period 2 | P | |
---|---|---|---|
Process measures | |||
Clinician reported use of Intubation Timeout tool, n (%)a | N/A | 161/221 (73) | — |
Nurse-reported team timeout, n (%)a | 128/191 (67) | 148/165 (90) | <.001 |
Use of evidence-based premedication, n (%) | 150/273 (55) | 191/236 (81) | <.001 |
Use of CPOE order set, n (%) | N/A | 100/166 (60) | — |
Balancing measures | |||
Time from decision to intubate to tube secured, median min [IQR] | 27 [18–45] | 33 [22–51] | .01 |
Infants decompensating while awaiting premedications from pharmacy, n (%) | 1/273 (0.4) | 1/236 (0.4) | 1 |
Medication errors, n (%) | 1/273 (0.4) | 2/236 (0.9) | .6 |
Potential medication side effects | |||
Hypotension, n (%) | 10/273 (3.7) | 3/236 (1.3) | .1 |
Chest wall rigidity (associated with opiate administration), n (%) | 3/273 (1.1) | 4/236 (1.7) | .7 |
Inability to extubate after INSURE procedure, n (%) | Not measured | 1/17 (6) | — |
N/A, not applicable.
Measures not reported for all eligible intubations.